RC
KURA icon

Rangeley Capital’s Kura Oncology KURA Stock Holding History

Rangeley Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
94,000
-7,220
-7% -$68.1K 0.94% 31
2026
Q1 		$823K Sell
101,220
-1,680
-2% -$14.4K 0.8% 39
2025
Q4 		$1.07M Sell
102,900
-17,100
-14% -$179K 0.89% 36
2025
Q3 		$1.06M Buy
120,000
+4,000
+3% +$28.5K 0.92% 26
2025
Q2 		$669K Buy
+116,000
New +$711K 0.8% 27

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Rangeley Capital's KURA Position: Q2 2026 in Review

Rangeley Capital reduced its Kura Oncology (KURA) stake by 7.1% in Q2 2026, selling an estimated $68.1K and leaving 94,000 shares worth $1.03M. The position accounts for 0.94% of the portfolio, ranked #31.

Rangeley Capital first reported a position in KURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.07M in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Rangeley Capital held 94,000 shares of Kura Oncology worth $1.03M as of Q2 2026.
  • Rangeley Capital sold 7,220 Kura Oncology shares in Q2 2026, an estimated $68.1K.
  • Kura Oncology made up 0.94% of Rangeley Capital's portfolio in Q2 2026, its #31 holding.
  • Rangeley Capital first reported a position in Kura Oncology in Q2 2025 and has held it in 5 quarters since.
  • Rangeley Capital's Kura Oncology position peaked at $1.07M in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.